Grants offered to identify mitochondrial biomarkers

News

Author: Parkinson's Life editorsPublished: 24 August 2017

Prep: Cook: Serves:

The Michael J Fox Foundation is offering one- to two-year grants for any Parkinson’s research that will develop or improve tools to identify mitochondrial biomarkers for the disease.

The goal of the initiative is to assist in the discovery of mitochondrial biomarkers to assess Parkinson’s diagnosis, patient stratification and disease progression. Any knowledge gained from the study will be applied to human biospecimens – biological material obtained for the purpose of research.

The deadline for submission of pre-proposals is 27 September 2017. Funding will be allocated in May 2018.

Last Month

Next Month

Go Back

Share this story

Comments

Interviews

“It’s so rewarding to help people improve their communication”

Find out about a new voice therapy app for Parkinson’s disease

Has the pandemic had some positive effects on people with Parkinson’s disease?

Researchers suggest it has improved health-related quality of life

Parkili: moving mountains for Parkinson’s

Mirjam was diagnosed in 2014, she's now climbed Kilimanjaro

Parkinson’s Europe co-founder Lizzie Graham wins World Parkinson Coalition award

Parkinson’s Europe co-founder Lizzie Graham has won a World Parkinson Coalition (WPC) award for her contribution to the Parkinson’s community. Lizzie is one of four people set to receive the Robin Elliott Award – which is given out every three years to individuals whose efforts best embody the goals and ethos of the WPC. She will be presented with the award in a ceremony at the World Parkinson’s Congress, which will be held in Barcelona later this year. Commenting on the news of Lizzie’s award, Parkinson’s Europe President, Veronica Clark, said: “Lizzie is Lizzie, and we love her for who she is and what she has done for us all – for people with Parkinson’s past and present and, I’m sure, future.” Lizzie co-founded the European Parkinson’s Disease Association (renamed Parkinson’s Europe last year) in 1992. She has since held several roles within the organisation – including secretary general and…

Study explores predictors of cognitive impairment in Parkinson’s disease

Cognitive impairment can affect some people with Parkinson’s – and may greatly impact their quality of life. Now, researchers in China have examined the possible risk factors for cognitive impairment in those with the condition. The study analysed data from 409 people with Parkinson’s within two years of their involvement in the Parkinson’s Progression Markers Initiative (PPMI) – an international study that follows people with and without the condition over time. The participants, who were newly diagnosed and experiencing normal cognitive function at the start of the research, were studied for at least five years. Published in ‘Frontiers in Aging Neuroscience’, the results indicate that older age at onset, high blood pressure and worse baseline motor symptoms may be among factors that could contribute to an increased risk of developing cognitive impairment. The researchers cautioned that “a larger sample and much more comprehensive assessment, and prolonged follow-up, will be required”.

Could frailty be a potential risk factor for Parkinson’s disease?

Frailty can refer to a reduction in physical function, and its attributes – including a slow walking speed and weak grip – are commonly experienced by people with Parkinson’s. Until now, there has been limited insight into the link between frailty and the risk of developing the condition over time. This is what led researchers at the Huazhong University of Science and Technology in China to analyse data from a large UK study, which was gathered over a 12-year period. Published in JAMA Neurology, the analysis found that frailty may be linked to an 87% higher risk of developing the condition. Commenting on the results, the researchers said: “These findings indicate that physical frailty is a potential risk factor for [Parkinson’s], and the assessment and management of frailty might have clinical significance in the at-risk population.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

Grants offered to identify mitochondrial biomarkers

News

Author: Parkinson's Life editorsPublished: 24 August 2017

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Interviews

“It’s so rewarding to help people improve their communication”

Special reports

Has the pandemic had some positive effects on people with Parkinson’s disease?

Perspectives

Parkili: moving mountains for Parkinson’s

Parkinson’s Europe co-founder Lizzie Graham wins World Parkinson Coalition award

Study explores predictors of cognitive impairment in Parkinson’s disease

Could frailty be a potential risk factor for Parkinson’s disease?

{title}

Subscribe

Grants offered to identify mitochondrial biomarkers

News

Author: Parkinson's Life editorsPublished: 24 August 2017

Last Month

Next Month

Share this story

Comments

Related articles

Interviews

“It’s so rewarding to help people improve their communication”

Special reports

Has the pandemic had some positive effects on people with Parkinson’s disease?

Perspectives

Parkili: moving mountains for Parkinson’s

Parkinson’s Europe co-founder Lizzie Graham wins World Parkinson Coalition award

Study explores predictors of cognitive impairment in Parkinson’s disease

Could frailty be a potential risk factor for Parkinson’s disease?

{title}

Subscribe

Sign in